抑制CDK1促进神经母细胞瘤中的免疫细胞死亡
Yiquan Li1, Tianyun Lan2, Rongpu Liang1
1Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Cancer management and research
|March 16, 2026
概括
抑制CDK1会减缓神经母细胞瘤的生长,并促进免疫细胞死亡. 这表明CDK1是改善神经母细胞瘤患者免疫治疗的潜在目标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 神经母细胞瘤利用免疫逃避策略,需要免疫治疗研究.
- 循环素依赖激酶1 (CDK1) 参与细胞循环调节和瘤异常,但其在神经母细胞瘤和免疫细胞死亡中的作用尚不清楚.
研究的目的:
- 研究神经母细胞瘤中CDK1表达的预后意义.
- 探索CDK1表达,免疫透和细胞因子水平之间的关系.
- 评估神经母细胞瘤中CDK1抑制的治疗潜力.
主要方法:
- 使用TCGA数据库和组织阵列分析神经母细胞瘤中CDK1表达的分析.
- 评估CDK1,免疫细胞透和细胞因子概况之间的相关性.
- 关于CDK1抑制剂 (RO-3306) 作用的体外和体内研究.
主要成果:
- 在晚期神经母细胞瘤中,CDK1过度表达,与预后不佳相关.
- 高CDK1表达与减少免疫细胞透和降低效应细胞因子水平 (IL-12,IFN-γ,IRF1) 有关.
- 抑制CDK1抑制了神经母细胞瘤的生长,并诱导免疫细胞死亡,其特征是CRT暴露,HSP70和HMGB1释放.
结论:
- CDK1抑制阻碍神经母细胞瘤的进展,并诱导损伤相关分子模式 (DAMPs),促进免疫激活.
- CDK1代表了一个潜在的预后生物标志物和治疗点,以提高神经母细胞瘤免疫治疗的有效性.
相关概念视频
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity
5.6K
5.6K
Negative Regulator Molecules
38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K


